A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Novartis
Novartis
Children's Oncology Group
Astellas Pharma Inc
St. Jude Children's Research Hospital
Baylor College of Medicine
Delta-Fly Pharma, Inc.
St. Jude Children's Research Hospital
Astellas Pharma Inc
City of Hope Medical Center
National Cancer Institute (NCI)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Baylor College of Medicine
Sanofi
Children's Oncology Group
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Servier